Evidence-Based Reviews

Stigma in dementia: It’s time to talk about it

Author and Disclosure Information

 

References

An open discussion

Larger studies and testing of diverse approaches are needed to better understand whether intergenerational initiatives or other approaches can genuinely modify stigmatizing attitudes in various dementia populations, especially considering language, health literacy, cultural preferences, and other needs. The identified effects on physical and mental health, quality of life, self-esteem, and behavioral symptoms further support the extensive, negative effects of self-stigma on PwD, and emphasize the need to develop and test interventions to ameliorate these effects.

We presented at a Stigma Symposium at the 2018 Gerontological Society of America Annual Scientific Meeting in Boston, Massachusetts.25 Attendees of this conference shared our concerns about the detrimental effects of stigma. The main question we were asked was “What can we do to reduce stigma?” Perhaps the most immediate response is that in order to move the stigma dial, clinicians need to recognize that stigma has multiple, broad-reaching, and negative effects on PwD and their families.6 Bringing the discussion into the open and targeting stigma at multiple levels needs to be addressed by clinicians, researchers, administrators, and society at large.

Bottom Line

Stigma has multiple, broad-reaching, and negative effects on persons with dementia and their families. In clinical practice, direct discussion that encourages reflection and the use of effective and sensitive communication can help to limit passing on stigmatizing beliefs and to reduce negative stereotypes associated with the disease. Anti-stigma messaging campaigns and public policy changes also can be used to address societal and social inequities of patients with dementia and their caregivers.

Related Resources

Pages

Recommended Reading

Novel plasma biomarkers may predict preclinical Alzheimer’s disease
Journal of Clinical Outcomes Management
Noncardiac surgery has 7% covert stroke rate in elderly
Journal of Clinical Outcomes Management
Blood-based signature helps predict status of early AD indicator
Journal of Clinical Outcomes Management
Boosting Alzheimer’s trial participation via Medicare Advantage ‘memory fitness programs’
Journal of Clinical Outcomes Management
BP control slowed brain damage in elderly hypertensives
Journal of Clinical Outcomes Management
ACE inhibitors may improve neuropsychiatric lupus
Journal of Clinical Outcomes Management
Elderly concussion patients who used statins had lower dementia risk
Journal of Clinical Outcomes Management
Coding variants in apolipoprotein B may be associated with early-onset Alzheimer’s disease
Journal of Clinical Outcomes Management
A/T/N system predicts cognitive decline
Journal of Clinical Outcomes Management
Anticholinergic drugs linked to dementia in older populations
Journal of Clinical Outcomes Management